These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17046771)

  • 1. Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens.
    Weedall GD; Preston BM; Thomas AW; Sutherland CJ; Conway DJ
    Int J Parasitol; 2007 Jan; 37(1):77-85. PubMed ID: 17046771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
    Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
    Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection.
    Polley SD; Tetteh KK; Lloyd JM; Akpogheneta OJ; Greenwood BM; Bojang KA; Conway DJ
    J Infect Dis; 2007 Jan; 195(2):279-87. PubMed ID: 17191173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
    Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species.
    Chenet SM; Pacheco MA; Bacon DJ; Collins WE; Barnwell JW; Escalante AA
    Infect Genet Evol; 2013 Dec; 20():239-48. PubMed ID: 24044894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversifying selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum in Thailand.
    Ohashi J; Suzuki Y; Naka I; Hananantachai H; Patarapotikul J
    PLoS One; 2014; 9(2):e90522. PubMed ID: 24587387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
    Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA
    PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population genetic structure analysis of thrombospondin-related adhesive protein (TRAP) as a vaccine candidate antigen in worldwide Plasmodium falciparum isolates.
    Mehrizi AA; Jafari Zadeh A; Zakeri S; Djadid ND
    Infect Genet Evol; 2020 Jun; 80():104197. PubMed ID: 31954917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
    Zeeshan M; Alam MT; Vinayak S; Bora H; Tyagi RK; Alam MS; Choudhary V; Mittra P; Lumb V; Bharti PK; Udhayakumar V; Singh N; Jain V; Singh PP; Sharma YD
    PLoS One; 2012; 7(8):e43430. PubMed ID: 22912873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites.
    Bauza K; Malinauskas T; Pfander C; Anar B; Jones EY; Billker O; Hill AV; Reyes-Sandoval A
    Infect Immun; 2014 Mar; 82(3):1277-86. PubMed ID: 24379295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited genetic diversity in the global Plasmodium vivax Cell traversal protein of Ookinetes and Sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development.
    Mehrizi AA; Torabi F; Zakeri S; Djadid ND
    Infect Genet Evol; 2017 Sep; 53():239-247. PubMed ID: 28600217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.
    Terheggen U; Drew DR; Hodder AN; Cross NJ; Mugyenyi CK; Barry AE; Anders RF; Dutta S; Osier FH; Elliott SR; Senn N; Stanisic DI; Marsh K; Siba PM; Mueller I; Richards JS; Beeson JG
    BMC Med; 2014 Oct; 12():183. PubMed ID: 25319190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-population genetic diversity of Plasmodium falciparum vaccine candidate antigens reveals geographic distance from a Central sub-Saharan African origin.
    Tanabe K; Mita T; Palacpac NM; Arisue N; Tougan T; Kawai S; Jombart T; Kobayashi F; Horii T
    Vaccine; 2013 Feb; 31(9):1334-9. PubMed ID: 23295064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
    Saul A
    J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax.
    Chenet SM; Tapia LL; Escalante AA; Durand S; Lucas C; Bacon DJ
    Malar J; 2012 Mar; 11():68. PubMed ID: 22417572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing malaria vaccines to circumvent antigen variability.
    Ouattara A; Barry AE; Dutta S; Remarque EJ; Beeson JG; Plowe CV
    Vaccine; 2015 Dec; 33(52):7506-12. PubMed ID: 26475447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria.
    Yadava A; Nurmukhambetova S; Pichugin AV; Lumsden JM
    J Infect Dis; 2012 May; 205(9):1456-63. PubMed ID: 22457289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico characterisation of putative Plasmodium falciparum vaccine candidates in African malaria populations.
    Ajibola O; Diop MF; Ghansah A; Amenga-Etego L; Golassa L; Apinjoh T; Randrianarivelojosia M; Maiga-Ascofare O; Yavo W; Bouyou-Akotet M; Oyebola KM; Andagalu B; D'Alessandro U; Ishengoma D; Djimde AA; Kamau E; Amambua-Ngwa A
    Sci Rep; 2021 Aug; 11(1):16215. PubMed ID: 34376744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum.
    Barry AE; Schultz L; Buckee CO; Reeder JC
    PLoS One; 2009 Dec; 4(12):e8497. PubMed ID: 20041125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population genetics, sequence diversity and selection in the gene encoding the Plasmodium falciparum apical membrane antigen 1 in clinical isolates from the south-east of Iran.
    Mehrizi AA; Sepehri M; Karimi F; Djadid ND; Zakeri S
    Infect Genet Evol; 2013 Jul; 17():51-61. PubMed ID: 23557839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.